These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28648948)

  • 21. Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity.
    Ramlov A; Tietze A; Khalil AA; Knap MM
    Lung Cancer; 2012 Sep; 77(3):561-6. PubMed ID: 22677428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer.
    Yao N; Qin Z; Chen M; Hu L; Ma J; Lu J; Tong S; Li N; Yao Y
    BMC Cancer; 2024 Aug; 24(1):953. PubMed ID: 39103758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
    Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
    Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.
    Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience.
    Naidoo J; Kehoe M; Sasiadek W; Hacking D; Calvert P
    Ir J Med Sci; 2014 Mar; 183(1):129-32. PubMed ID: 23760883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.
    Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
    Stanic K; Vrankar M; But-Hadzic J
    Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.
    Chen Y; Li J; Hu Y; Zhang Y; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2016 Dec; 192(12):905-912. PubMed ID: 27605237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
    Patel S; Macdonald OK; Suntharalingam M
    Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
    Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
    Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
    Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
    Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
    Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
    Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
    Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML
    Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.